Intelligence Β· Clinical Pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs
1,839

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Page 17 of 39

  1. Instillation - EXPAREL

    Pacira Ireland Limited

    Mammoplasty

    approved small molecule completed

    1 trial
  2. Insulin

    The First People's Hospital of Lianyungang

    Brain Injuries

    approved small molecule active

    1 trial
  3. Insulin

    The First People's Hospital of Lianyungang

    Acute Pancreatitis

    approved small molecule active

    1 trial
  4. Insulin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatitis, Acute

    approved small molecule active

    1 trial
  5. Insulin Glargine

    Eli Lilly and Company

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial
  6. Insulin Glargine

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule completed

    2 trials
  7. Insulin glulisine

    Sanofi Pasteur

    Diabetes Mellitus, Type 1

    approved small molecule completed

    1 trial
  8. Insulin lispro low mixture

    Eli Lilly and Company

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial
  9. Intensive statin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule active

    1 trial
  10. Intranasal corticosteroids (INCS) combined with oral antihistamines (OAH) used for treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Allergic Rhinitis

    approved small molecule active

    1 trial
  11. Intranasal dexmedetomidine-esketamine

    The First People's Hospital of Lianyungang

    Adenotonsillectomy

    approved small molecule active

    1 trial
  12. Intraosseous

    Hospital Authority, Hong Kong

    Cardiac Arrest

    approved other completed

    1 trial
  13. Intraosseous Morphine

    Hospital Authority, Hong Kong

    Pain Postoperative

    approved other active

    1 trial
  14. Intrathecal (injected into the spinal fluid) DepoCyt

    Pacira Ireland Limited

    Meningeal Neoplasms

    approved small molecule completed

    1 trial
  15. Intrathecal morphine injection

    Pacira Ireland Limited

    Pain

    approved small molecule terminated

    1 trial
  16. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Fever

    approved small molecule terminated

    1 trial
  17. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Obesity

    approved small molecule completed

    1 trial
  18. Intravenous Immunoglobulins, Human

    The First People's Hospital of Lianyungang

    Guillain-Barre Syndrome

    approved small molecule active

    1 trial
  19. Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients with Atrial Fibrillation

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmias, Cardiac

    approved small molecule active

    1 trial
  20. Intravenous Treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    1 trial
  21. Intravenous fentanyl citrate

    BRIGHT MINDS BIOSCIENCES INC.

    Peer Review, Research

    approved small molecule completed

    1 trial
  22. Intravenous ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    3 trials
  23. Intravenous thrombolysis + edaravone

    The First People's Hospital of Lianyungang

    Ischemic Stroke

    approved small molecule active

    1 trial
  24. Intravenous/Subcutaneous Treprostinil; Oral Treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    1 trial
  25. Intravitreal Aflibercept

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule terminated

    2 trials
  26. Intravitreal Aflibercept Injection

    Regeneron UK Limited

    Cystoid Macular Edema

    approved small molecule completed

    1 trial
  27. Intravitreal Aflibercept Injection (IAI)

    Regeneron UK Limited

    Chorioretinal Vascular Disease

    approved small molecule completed

    1 trial
  28. Intravitreal Aflibercept Injection (IAI)

    Regeneron UK Limited

    Age - Related Macular Degeneration (AMD)

    approved small molecule completed

    1 trial
  29. Intravitreal Aflibercept Injection 2mg

    Regeneron UK Limited

    Neovascular Age-related Macular Degeneration

    approved small molecule active

    2 trials
  30. Intravitreal aflibercept injection

    Regeneron UK Limited

    Macular Degeneration

    approved small molecule completed

    1 trial
  31. Intravitreal aflibercept injection 2.0mg

    Regeneron UK Limited

    Polypoidal Choroidal Vasculopathy

    approved small molecule completed

    1 trial
  32. Investigational 23-valent PPV

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    2 trials
  33. Investigational live attenuated varicella vaccine

    Sinovac Research and Development Co.,

    Varicella

    approved mab active

    4 trials
  34. Invokana 100 mg film-coated tablets, Xigduo 5 mg/850 mg film-coated tablets, Vokanamet 150 mg/850 mg film-coated tablets, Forxiga 10 mg film-coated tablets, Vokanamet 50 mg/1,000 mg film-coated tablets, Invokana 300 mg film-coated tablets, Forxiga 5 mg film-coated tablets, Vokanamet 50 mg/850 mg film-coated tablets, Synjardy 12.5 mg/1,000 mg film-coated tablets, Synjardy 12.5 mg/850 mg film-coated tablets, Jardiance 25 mg film-coated tablets, Synjardy 5 mg/1,000 mg film-coated tablets, Xigduo 5 mg/1,000 mg

    Wuhan Createrna Science and Technology Co., Ltd

    Type 2 diabetes mellitus

    approved small molecule active

    1 trial
  35. Iohexol 300 mg I/ml solution for injection, MORPHINE (CHLORHYDRATE) RENAUDIN 1 mg/ml, solution injectable

    Tour Hekla

    Evaluation of the CKD-Epi score to identify a glomerular filtration threshold predictive of morphine failure at usual dosage, using a reference method for assessing renal function: iohexol clearance. All other aspects of the protocol are part of standard care practice.

    approved small molecule active

    1 trial
  36. Iomeron 400 mgI/ml solution for injection

    The George Institute

    Thoracic neoplasm

    approved small molecule active

    1 trial
  37. Irinotecan liposomes combined with cisplatin/carboplatin

    The First People's Hospital of Lianyungang

    Neuroendocrine Tumors

    approved small molecule active

    1 trial
  38. Isatuximab, bortezomib, lenalidomide, dexamethason

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    approved small molecule active

    1 trial
  39. Isoniazid

    United Therapeutics Europe Ltd

    Tuberculosis

    approved small molecule active

    2 trials
  40. Isoniazid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Tuberculosis, Pulmonary

    approved small molecule active

    1 trial
  41. Isoniazid Aminosalicylate Tablets

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Reinfection Pulmonary Tuberculosis

    approved small molecule active

    1 trial
  42. Isotonic hydration fluid and recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule terminated

    1 trial
  43. Isotretinoin

    VYNE Therapeutics

    Acne Vulgaris

    approved small molecule completed

    1 trial
  44. Ivabradine + Usual Care

    The University of Hong Kong

    Atrial Fibrillation (Permanent)

    approved small molecule active

    1 trial
  45. Ixazomib

    Takeda

    Relapsed and/or Refractory Multiple Myeloma

    approved small molecule terminated

    4 trials
  46. Ixazomib

    The First People's Hospital of Lianyungang

    Multiple Myeloma

    approved small molecule completed

    1 trial
  47. Ixekizumab

    Hospital Authority, Hong Kong

    Plaque Psoriasis

    approved mab active

    1 trial
  48. JAK Inhibitor

    The First People's Hospital of Lianyungang

    Dermatomyositis, Adult Type

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources Β· All pipeline programs